Gene Query: GOLGA7

Dataset Description Geneva Score
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 55.2
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 55.2
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 29.2
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 27.61
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 27.61
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 20.83
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 17.51
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 17.51
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 16.49
The age and genomic integrity of neurons after cortical stroke in humans 16.43
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 16.41
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 16.05
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 16.03
Selective suppression of endothelial cytokine production by progesterone receptor 16.03
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 15.26
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 14.55
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 14.48
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 13.51
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 13.51
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 13.48
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 13.41
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 12.95
Mapping interactions for the TNIP2 hub protein 12.87
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 12.8
TCF7L1 knockdown in pancreatic cancer 12.65
BAF controls genome accessibility 12.46
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 12.15
Unique features and clinical importance of acute alloreactive immune responses 11.8
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 11.53
Functional role of SLIT2 and ROBO1 in trophoblasts 11.34
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 11.31
JunB control of keratinocyte-mediated inflammation [RNA-seq] 10.82
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 10.82
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 10.43
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 10.41
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 9.94
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 9.87
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 9.87
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.84
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 9.76
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 9.68
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 9.63
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 9.6
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 9.45
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 9.33
RNA-seq analyisis of PUM2 knockout cells 9.31
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 9.03
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.94
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.82
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 8.73
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 8.72
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 8.66
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 8.64
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 8.6
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 8.58
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 8.47
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.38
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 8.35
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 8.29
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 8.24
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 8.22
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 8.18
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 8.13
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 8.13
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 8.1
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 8.1
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 8.08
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 8.07
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 8.07
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 7.94
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 7.88
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.88
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 7.64
Transcriptomic analysis of human tonsillar TFH subsets 7.64
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 7.62
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.59
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.57
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 7.54
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 7.5
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 7.41
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 7.41
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 7.37
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 7.37
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 7.34
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 7.32
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 7.31
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 7.27
Crizotinib v. DMSO in SW480 cells 7.25
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 7.21
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 7.2
Effect of disulfiram treatment on pediatric high grade glioma 7.19
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 7.08
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 7.08
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.05
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 7.03
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 7.03
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 7.02
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.99
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.99
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.9
RNAseq of HEK293 cells after Chtop knockdown 6.9
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 6.84
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 6.76
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 6.76
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 6.71
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 6.66
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 6.64
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 6.63
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 6.57
Transcriptomic analyssis following EHMT1/2 inhibition 6.56
p63 controls the enhancer landscape during keratinocyte differentiation 6.54
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 6.54
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 6.48
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.45
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 6.36
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 6.31
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 6.31
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.29
SLIGRL-induced gene expression changes in NHEK cells 6.29
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.28
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.28
scRNASeq analysis of cycling cardiomyocytes 6.24
Gene expression profile of human iPSC-derived nephron progenitor cells 6.2
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.19
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 6.19
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.18
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 6.18
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 6.11
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 6.09
Transcriptome-wide identification of CELF2 functional targets in T cells 6.07
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 6.06
A transcriptome-wide divergence in protein translation scales with LIN28B expression 6.02
EWSR1 influences alternative splicing through direct and indirect mechanisms 5.84
Region-specific Innate Antiviral Responses of the Human Epididymis 5.84
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.77
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.77
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.76
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.7
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 5.65
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 5.63
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 5.55
Paxillin regulates genomic networks in prostate cancer [LNCaP] 5.54
RNAseq analysis of ESRP regulated splicing events in prostate cancer 5.52
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 5.51
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 5.5
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 5.49
Functional role of CPPED1 in trophoblasts. 5.45
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 5.42
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.41
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.37
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 5.34
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 5.33
Identifying the molecular mode of action of itraconazole in colorectal cancer 5.33
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 5.31
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 5.3
Patient-derived luminal breast cancer xenografts with progestins 5.29
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 5.29
SLAM-seq for K562 endogenous mRNA decay 5.29
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.29
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 5.29
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.28
Pharmacologic inhibition of STAT5 in AML 5.27
CROP-Seq in Primary Human T Cells 5.27
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 5.26
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 5.26
Expression level comparison under dividing and quiescent states in human primary fibroblasts 5.24
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.24
HNRNPL and its RNA Targets in Prostate Cancer 5.21
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 5.21
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.21
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 5.19
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 5.19
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 5.19
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.09
Effect of mitochondria deficiency on senescence-associated gene expression 5.09
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 5.06
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.05
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 5.04
PNET animal model: new insights (II) 5.04
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 5.04
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.0
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 4.99
Examining serotonergic neuron differentiation from human iPSCs 4.97
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.95
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 4.94
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 4.94
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.94
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 4.93
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.92
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 4.9
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.86
Paxillin regulates genomic networks in prostate cancer [PC3] 4.84
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 4.83
Comprehensive comparative analysis of 5’ end RNA sequencing methods 4.82
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 4.78
PGE2 mediated gene expression changes in human cervical stromal cells 4.77
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 4.76
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 4.73
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 4.72
Tpl-2 and MEK small molecule inhibitors 4.71
Tpl-2 small molecule project 4.71
CircRNAome diversity in human mature B-cells, T-cells and monocytes 4.71
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 4.7
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 4.69
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 4.68
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 4.68
RNA sequencing of BT142 and TS603 cell lines 4.68
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 4.68
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 4.68
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 4.68
Survival of pancreatic cancer cells lacking KRAS function 4.66
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 4.66
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 4.65
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 4.65
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 4.61
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 4.61
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 4.6
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 4.6
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.58
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 4.57
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.57
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.55
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 4.55
Identification of global regulators of T-helper cell lineage specification 4.55
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 4.54
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 4.54
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.53
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.53
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.53
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.51
mRNA expression profile of Lymphocytes 4.41
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.4
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 4.39
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 4.38
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 4.36
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 4.35
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 4.35
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 4.31
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 4.3
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.26
Effect of CHKA knockdown on C4-2 cell transcriptome 4.25
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.22
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 4.21
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.19
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.19
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 4.15
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 4.15
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.14
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.14
RNA-seq of YB5 cells treated with Proscillaridin A 4.14
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 4.07
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.06
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 4.04
CD86 regulates a pro-survival signal in myeloma cells 4.02
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.01
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 3.99
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 3.99
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.96
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.93
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.93
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.91
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.9
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 3.85
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 3.85
Knockdown of ADNP in HCT116 colon cancer cells 3.85
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.77
Effect of PBK knockdown on C4-2 cell transcriptome 3.75
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.75
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.75
TT-Seq captures the human transient transcriptome 3.74
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.74
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.71
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.7
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.7
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.62
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 3.62
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 3.59
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 3.59
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.58
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 3.58
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 3.58
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 3.56
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 3.56
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.56
Tracking distinct RNA populations using efficient and reversible covalent chemistry 3.52
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.52
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.5
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.47
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.47
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.44
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 3.43
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 3.42
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.41
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.41
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 3.39
naive T cell heterogeneity after neonatal thymectomy 3.24
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.21
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.21
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 3.2
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 3.18
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.16
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.14
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 3.13
Lysine benzoylation is a novel histone mark [RNA-seq] 3.13
Lysine benzoylation is a novel histone mark 3.13
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 3.11
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 3.06
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 3.04
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 2.94
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.91
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.89
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.89
RNA-seq of RKO cells with cTAZ KO or putback 2.88
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.83
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 2.83
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.82
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.81
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.81
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.78
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 2.76
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 2.76
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 2.75
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.74
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.74
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.74
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.68
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.66
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.65
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.65
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.61
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.61
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.57
Activity-dependent transcriptional changes in human neurons 2.57
Exploring ILF2 regulatory genes by next-generation sequencing 2.54
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 2.47
Patient-derived xenograft platform for metastatic melanoma 2.46
LIN28A Over-expression RNAseq 2.38
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.34
Induced DNA demethylation, genome instability and transcription 2.34
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.32
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.3
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.28
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 2.22
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.22
Dynamic 3D chromosomal landscapes in acute leukemia 2.15
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.15
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.14
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.14
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.09
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.07
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.06
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 2.05
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.05
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.04
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.04
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.04
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.01
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.01
Single-cell analysis of adult human ovary using 10X genomics 1.99
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.99
Intrahepatic MAIT cell gene expression revealed by RNA-seq 1.98
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.96
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.95
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.94
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.93
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.92
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.9
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.88
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.87
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.85
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.83
Trans-differentiation of human adult peripheral blood T cells into neurons 1.8
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.8
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.8
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 1.79
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 1.79
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.72
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.72
Positively selected enhancer elements endow tumor cells with metastatic competence 1.71
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.7
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.66
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.65
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.6
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.59
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.58
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.58
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.56
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.56
HBEC-shp53-PCHD7 1.54
Functional significance of the HIV-1 Tat signature amino acid residues 1.51
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.51
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.49
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.49
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.48
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.48
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.48
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.47
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.47
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 1.45
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.41
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.39
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.39
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.33
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.33
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.29
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.29
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.27
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.2
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.16
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.15
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.15
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.12
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.12
FOXP1 orchestration of ASD-relevant signaling pathways. 1.08
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.98
Dermal endothelial cells of type 2 diabetic patients 0.97
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.97
RNA expression analysis upon JMJD1C depletion 0.97
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.94
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.93
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.93
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.89
Human Treg IL-12 stimulation 0.87
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.86
RNAseq in Alzheimer's Disease patients 0.86
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.85
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.85
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 0.84
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.84
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.83
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.81
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.8
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.76
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.76
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.75
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.75
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.74
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.71
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.71
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 0.7
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.69
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.68
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.68
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.67
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.67
Expression analysis of the TAF1 syndrome 0.67
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.66
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.54
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.5
Discovering human diabetes-risk gene function with genetics and physiological assays 0.47
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.47
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.47
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.46
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 0.36
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.35
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.34
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.33
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.33
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.33
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.31
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.31
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.31
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.3
Transcriptional landscape changes during human embryonic stem cell derivation 0.3
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.28
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.28
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.28
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.27
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.25
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.24
Global transcriptome analysis of WT versus HEB-/- hESCs 0.24
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 0.21
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 0.21
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 0.2
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 0.19
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.17
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.16
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.16
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.15
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.14
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.14
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.14
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.13
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.1
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.09
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.09
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.09
MicroRNA-125a-5p overexpression in human macrophages 0.08
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.07
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.05
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.04
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.03
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.03
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.03
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation